-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on 10x Genomics, Raises Price Target to $40

Benzinga·06/24/2026 14:20:15
Listen to the news
Barclays analyst Luke Sergott maintains 10x Genomics (NASDAQ:TXG) with a Overweight and raises the price target from $30 to $40.